Armed Forces serving on active duty who is diagnosed with a covered condition to participate in a clinical trial that is conducted using funding awarded under this section and is authorized pursuant to section 505 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 ), without regard to— (1) whether the clinical trial involves a substance included in the schedule under section 202 of the Controlled Substances Act ( 21 U.S.C. 812 )